SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-002417
Filing Date
2022-03-02
Accepted
2022-03-02 16:31:06
Documents
14
Period of Report
2022-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 20804
  Complete submission text file 0001654954-22-002417.txt   136631

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220228.xsd EX-101.SCH 5822
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220228_lab.xml EX-101.LAB 13568
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20220228_cal.xml EX-101.CAL 890
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220228_pre.xml EX-101.PRE 8583
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20220228_def.xml EX-101.DEF 2095
8 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3311
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 22704053
SIC: 2834 Pharmaceutical Preparations